全文获取类型
收费全文 | 2940篇 |
免费 | 220篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 60篇 |
妇产科学 | 55篇 |
基础医学 | 494篇 |
口腔科学 | 30篇 |
临床医学 | 280篇 |
内科学 | 875篇 |
皮肤病学 | 23篇 |
神经病学 | 278篇 |
特种医学 | 78篇 |
外科学 | 246篇 |
综合类 | 18篇 |
预防医学 | 271篇 |
眼科学 | 13篇 |
药学 | 242篇 |
肿瘤学 | 174篇 |
出版年
2023年 | 13篇 |
2022年 | 28篇 |
2021年 | 37篇 |
2020年 | 43篇 |
2019年 | 47篇 |
2018年 | 76篇 |
2017年 | 56篇 |
2016年 | 44篇 |
2015年 | 48篇 |
2014年 | 97篇 |
2013年 | 133篇 |
2012年 | 196篇 |
2011年 | 205篇 |
2010年 | 108篇 |
2009年 | 108篇 |
2008年 | 181篇 |
2007年 | 184篇 |
2006年 | 169篇 |
2005年 | 170篇 |
2004年 | 151篇 |
2003年 | 162篇 |
2002年 | 167篇 |
2001年 | 67篇 |
2000年 | 61篇 |
1999年 | 78篇 |
1998年 | 32篇 |
1997年 | 38篇 |
1996年 | 32篇 |
1995年 | 37篇 |
1994年 | 26篇 |
1993年 | 18篇 |
1992年 | 42篇 |
1991年 | 44篇 |
1990年 | 27篇 |
1989年 | 28篇 |
1988年 | 17篇 |
1987年 | 18篇 |
1986年 | 17篇 |
1985年 | 16篇 |
1984年 | 24篇 |
1983年 | 17篇 |
1982年 | 12篇 |
1981年 | 11篇 |
1980年 | 10篇 |
1979年 | 9篇 |
1978年 | 11篇 |
1977年 | 6篇 |
1972年 | 5篇 |
1970年 | 4篇 |
1967年 | 6篇 |
排序方式: 共有3164条查询结果,搜索用时 15 毫秒
1.
2.
Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation. 总被引:3,自引:0,他引:3
Femke J Bijlsma Joyce vanKuik Marcel G J Tilanus Nicolaas deJonge Erik H Rozemuller Jan G van den Tweel Frits H J Gmelig-Meyling Roel A deWeger 《The Journal of heart and lung transplantation》2002,21(3):340-346
BACKGROUND: The cytokine interleukin-4 (IL-4) is secreted mainly by activated T lymphocytes and characterizes the T-helper 2 (Th2) sub-type. In transplantation Th2 cells are believed to induce graft tolerance. Previous studies revealed that patients with a relatively high frequency of IL-4 producing helper T lymphocytes (HTL) before heart transplantation (HTX) had no or less rejection episodes compared with patients with a low frequency of IL-4 producing HTL. Three single nucleotide polymorphisms (SNPs) have been identified in the promoter region of the IL-4 gene, which influence promoter strength. We investigated whether there was a correlation between SNP genotypes in the IL-4 promoter and heart failure, and rejection after HTX. METHODS: Seventy HTX patients, 61 donors, and 36 controls were genotyped for the 3 SNPs by sequencing. RESULTS: Of the SNPs at -285 and -81, only the C and A alleles, respectively, were found in this study. Both alleles were found for the -590 SNP. No relation between patient genotype of the SNP at -590 and heart failure and rejection was found. However, incidence of rejection was significantly lower in patients that received a donor heart with the T-positive genotype compared with patients that received a heart from a T-negative donor. Patients who had the T-negative genotype and received a heart from a T-positive donor, suffered significantly less from rejection than T-negative patients that received a T-negative donor heart. This was not significant in the T-positive patient group. CONCLUSIONS: This indicates that IL-4 production within the donor heart and by cells from the donor is important for reducing incidence of episodes of rejection. 相似文献
3.
Marcel J. Kooy Wouter S. Dessing Esther F. Kroodsma Steven R. J. G. Smits Esther H. Fietje Martine Kruijtbosch Peter A. G. M. De Smet 《Pharmacy World & Science》2007,29(2):81-89
OBJECTIVE: According to a report published by the federation of Dutch patients' associations, patients would like to see a pharmacist, who acts more as a personal adviser. This raised the question, how often Dutch community pharmacists have personal consultations with their patients in daily practice, on which factors this depends, and what kind of topics are discussed during these meetings. SETTING: Community pharmacies in the Netherlands. METHOD: A questionnaire was distributed among 800 randomly selected pharmacies. Questions were restricted to consultations characterized by one-to-one contact, drug therapy related content, and adequate privacy. These consultations were labelled as pharmaceutical consultations in private to distinguish them from other contacts between pharmacists and patients. MAIN OUTCOME MEASURE: Number, content, and character of consultations. RESULTS: 198 (24.8%) community pharmacies responded. The pharmacists provide an average of roughly 1.2 consultations in private per working day. The vast majority of respondents provided face-to-face and telephone consultations (94.4 and 91.9%, respectively), only a minority gave consultations by e-mail (30.8%). These consultations primarily dealt with topics related to medication safety. The mean overall time spent was 290 min per month. A relatively high frequency of personal consultations was significantly associated with the absolute number of full-time equivalent pharmacists in the pharmacy. CONCLUSION: The frequency of pharmaceutical consultations in private is low, but may be improved by reorganisation of the pharmacist's activities. The possibility of personal consultations by e-mail is not yet well-developed. Further research is needed to assess the patient's view of pharmaceutical consultations in private. 相似文献
4.
5.
Martin Klomp Peter M. Van den Bergh Frits J. H. Harinck 《Child & youth care forum》1997,26(5):343-355
In child and youth care in the Netherlands, systematic planning of treatment is more and more considered to be a condition
for effective and well founded treatment. Although workers are convinced of the benefits of treatment plans, treatment planning
is not yet a natural and integrated part of residential care. There are several pressure points. In this article a model of
treatment planning will be presented that contributes to an answer to these pressure points. The theoretical bases and the
practical implications of this model will be discussed. 相似文献
6.
Mark Hans Emanuel M.D. Augustinus Hart M.Sc. Kees Wamsteker M.D. Frits Lammes M.D. 《Fertility and sterility》1997,68(5):881-886
Objective: To determine the contribution of several variables to fluid loss during transcervical resection of submucous myomas.Design: An observational study using multiple linear regression analyses.Setting: A university-affiliated training hospital and a university department of clinical epidemiology and biostatistics.Patient(s): Patients with submucous myomas.Intervention(s): Transcervical resection of submucous myomas and monitoring of fluid loss.Main Outcome Measure(s): Patient age, uterine enlargement, treatment with GnRH analogues or 8-ornithine-vasopressin, type of anesthesia, number of myomas, intramural extension of the myoma (type of myoma), and operating time were tested as variables.Result(s): Only intramural extension of the myoma and operating time were obviously related to fluid loss. For the other variables, such a relation was weak at best. The relation between fluid loss and operating time was not modified by any of the other variables.Conclusion(s): Because fluid loss is an important limiting factor in the transcervical resection of submucous myomas, special attention should be paid to reduction of the operating time and preoperative assessment of the intramural extension of the myoma to guide appropriate patient selection. 相似文献
7.
A Hennipman J Smits B van Oirschot J C van Houwelingen G Rijksen J P Neyt J A Van Unnik G E Staal 《Tumour biology》1987,8(5):251-263
The activities of hexokinase, phosphofructokinase, aldolase, enolase and pyruvate kinase were studied in breast cancer tissues, in comparison to benign breast disease and normal breast tissues. The enzyme activities in breast cancer were significantly increased compared to normal and benign breast tissues (p less than 0.001). Also the increase in activity in benign disease compared to normal was statistically significant (p less than 0.001). Within the group of benign diseases, fibroadenomas could be distinguished from fibrocystic disease, the former generally showing higher activities compared to the latter (p less than or equal to 0.05). Carcinoma subgroups, classified according to their histology, could not be recognized enzymologically. In addition, isozyme composition of pyruvate kinase and enolase was studied. We did not find a significant shift towards K type pyruvate kinase expression in benign disease compared to normal breast tissues. Also fibroadenomas did not differ from fibrocystic disease. However, the amount of K type pyruvate kinase in carcinomas proved to be significantly higher in comparison to benign disease and normal breast tissues (p less than 0.001). Expression of alpha gamma-enolase in normal breast tissue was virtually absent. In benign disease only a minority of specimens did show the hybrid alpha gamma-enolase. Nearly all carcinomas had alpha gamma-enolase expression and in 20% of the carcinomas gamma gamma-enolase could be detected (so-called neuron-specific enolase). By discriminant analysis, the function giving the best discrimination compared to the histological data was based on natural logarithm aldolase and the total of gamma-enolase subunits. Contrary to expectation, the regulator enzymes of glycolysis; i.e., hexokinase, phosphofructokinase and pyruvate kinase were not included in this discriminant function. The best fit produced a 90% correct classification in both benign and malignant disease. If these findings are confirmed to a larger series, the discrimination is sufficiently strong to form the basis of a clinically useful tool. 相似文献
8.
9.
Joseph Smits 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》1888,28(3):238-242
Ohne Zusammenfassung 相似文献
10.
David M Spiegel Beverly Farmer Gerard Smits Michel Chonchol 《Journal of renal nutrition》2007,17(6):416-422
OBJECTIVE: This study was designed to evaluate the efficacy of magnesium carbonate as a phosphate binder in hemodialysis patients. DESIGN: This study was a prospective, randomized, open-label trial comparing magnesium carbonate/calcium carbonate versus calcium acetate as a sole phosphate binder. SETTING: This study involved outpatient hemodialysis. PARTICIPANTS: We recruited 30 stable hemodialysis patients without a history of frequent diarrhea. INTERVENTION: After receiving informed consent, we randomized patients 2:1 to magnesium carbonate versus calcium acetate. The dose of each binder was titrated to achieve the Kidney Disease Outcomes Quality Initiative (K/DOQI) phosphate target of <5.5 mg/dL. MAIN OUTCOME MEASURE: The efficacy-phase serum phosphorus concentration and the percentage of patients meeting K-DOQI targets for phosphorus, along with the daily elemental calcium intake, were the primary outcome measures. RESULTS: Magnesium carbonate provided equal control of serum phosphorus (70.6% of the magnebind group and 62.5% of the calcium acetate group had their average serum phosphorus within the K-DOQI target during the efficacy phase), while significantly reducing daily elemental calcium ingestion from phosphate binders (908 +/- 24 vs. 1743 +/- 37 mg/day, P < .0001). CONCLUSION: Magnesium carbonate was generally well-tolerated in this selected patient population, and was effective in controlling serum phosphorus while reducing elemental calcium ingestion. 相似文献